SAN CLEMENTE, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Results
Second quarter 2015 revenue was $83.8 million, compared to $78.7 million in the same period last year. GAAP net income for the second quarter of 2015 was $13.6 million, or $0.83 per diluted share, as compared to GAAP net income of $5.9 million, or $0.38 per diluted share, for the second quarter of 2014. Adjusted diluted earnings per share for the second quarter of 2015 was $0.97 as compared to $0.51 for the second quarter of 2014. Also, adjusted EBITDA was $28.1 million for the second quarter of 2015 as compared to $16.3 million for the second quarter of 2014.
Vivek Jain, ICU Medical's Chief Executive Officer, said, "Our second quarter results were above our expectations as we achieved growth in both our direct and OEM channels. Based on our results for the first half of 2015 and expectations for the remainder of the year, we are adjusting our full year 2015 guidance."
Revenues by market segment for the three months ended June 30, 2015 and 2014 were as follows:
For full article, please click here.Help employers find you! Check out all the jobs and post your resume.
